Skip to content

Multicenter Prospective Cohort Study of Twin Maternal-Child Dyads in China

Multicenter Prospective Cohort Study of Twin Maternal-Child Dyads in China

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06414655
Acronym
ChiTwiMC
Enrollment
2000
Registered
2024-05-16
Start date
2024-03-01
Completion date
2026-11-30
Last updated
2024-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High Risk Pregnancy, Pre-Eclampsia, Pre-Term, Twin Dichorionic Diamniotic Placenta, Twin Monochorionic Diamniotic Placenta, Twin Placenta, Twin Pregnancy, Antepartum Condition or Complication, Twin to Twin Transfusion as Antepartum Condition

Brief summary

Multicenter Prospective Cohort Study of Twin Maternal-Child Dyads in China (ChiTwiMC) is supported by National Key Research and Development Program of China - Reproductive Health and Women's and Children's Health Protection Project. This project is funded by the Ministry of Science and Technology of China under grant number 2023YFC2705900. The ChiTwiMC cohort is led by Professor Wei Yuan from the Department of Gynecology and Obstetrics at Peking University Third Hospital.

Detailed description

The ChiTwiMC Cohort focusing on the serious complications of twin pregnancy, establish a multicenter large prospective mother-child cohort of twin pregnancy covering pregnancy→neonatal period→early childhood, and a multi-variety, multi-stage biobank for the study of adverse outcomes of twin pregnancy. The ChiTwiMC Cohort is planning to recruit 2000 pregnant women aged 18-45 years from 9 large obstetrical center of major University-affiliated Hospitals across China, between December 2023 and May 2026. All women will be enrolled prior to 14 wks of gestation, pregnancy was followed up at 22-28 wks, 30-38 wks of gestation, delivery, postpartum 42 days, 6 months, 12 months. Data including demographics, medical history, reproductive history, clinical diagnosis, treatment information, and pregnancy and birth outcomes will be collected via electronic data capture system. Track the outcome of severe maternal-fetal complications and early neonatal outcomes of twins, and collect biological samples, including peripheral venous blood, hair and cervicovaginal secretions from pregnant women, placenta tissue, amniotic fluid and unbilical cord blood at delivery, meconium and hair from newborns, buccal mucosa from infants and peripheral venous blood from the husband.

Interventions

None listed

Sponsors

First Affiliated Hospital, Sun Yat-Sen University
CollaboratorOTHER
Chongqing Medical University
CollaboratorOTHER
Shengjing Hospital
CollaboratorOTHER
Peking University
CollaboratorOTHER
Nankai University
CollaboratorOTHER
Shanghai First Maternity and Infant Hospital
CollaboratorOTHER
The First Affiliated Hospital of Anhui Medical University
CollaboratorOTHER
International Peace Maternity and Child Health Hospital
CollaboratorOTHER
The Second Hospital of Shandong University
CollaboratorOTHER
Shandong Provincial Hospital
CollaboratorOTHER_GOV
Peking University Third Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Twin pregnancies * Female aged between 18-45 years * Gestational age is less than 14 weeks * Planning to receive prenatal healthcare and delivery service at the study hospital * Signing informed concent and willing to participate

Exclusion criteria

* Women with mental disorders or serious maternal illness that is not eligible to participate * Inability to provide informed consent * Pregnant women not registered in our hospital

Design outcomes

Primary

MeasureTime frameDescription
Children's heightWithin 1 year after deliveryEach child is measured twice. If the difference is less than 0.1 cm, the average of the two measurements is taken. If the difference is greater than 0.1 cm, the measurement is repeated.
Children's weightWithin 1 year after deliveryEach newborn is measured twice. If the difference is less than 0.01 kg, the average of the two measurements is taken. If the difference is greater than 0.01 kg, the measurement is repeated.
Rate of preterm deliveryFrom inclusion to deliveryPreterm delivery is defined as delivery between 28 and 37 gestational weeks.
Rate of preeclampsiaFrom inclusion to deliveryPreeclampsia is defined as the condition occurring in pregnant women after 20 weeks of gestation, characterized by systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg, accompanied by any of the following: a urinary protein quantification ≥0.3 g/24 h, or a urine protein/creatinine ratio ≥0.3, or random urine protein ≥ (+) (as a method of examination when protein quantification is not feasible). In the absence of proteinuria, the condition may still be diagnosed if there is involvement of any organ or system, including but not limited to critical organs such as the heart, lungs, liver, kidneys, or abnormalities in the hematological, digestive, or neurological systems, as well as complications affecting the placenta-fetus.
Rate of twin-to-twin transfusion syndrome (TTTS)From inclusion to deliveryTTTS is diagnosed in monochorionic diamniotic twin pregnancies when there is a discordance in amniotic fluid volumes, with one fetus exhibiting polyhydramnios and the other oligohydramnios. Specifically, before 20 weeks of gestation, the condition is diagnosed if one fetus (the recipient) has a deepest vertical pocket (DVP) of amniotic fluid ≥8cm, while the other fetus (the donor) has a DVP ≤2cm; after 20 weeks of gestation, the diagnosis is made if one fetus (the recipient) has a DVP ≥10cm, while the other fetus (the donor) has a DVP ≤2cm.
Rate of selective fetal growth restriction (sFGR)From inclusion to deliverysFGR is diagnosed in monochorionic diamniotic twin pregnancies when one fetus has an estimated fetal weight below the 10th percentile for its gestational age, and there is a discrepancy of ≥25% in the estimated fetal weights between the two fetuses.
Rate of fetal brain injuryFrom inclusion to deliveryFetal brain injury is an abnormality in the structural and functional integrity of the cerebrum, cerebellum, or brainstem during the gestational period, caused by various factors such as hypoxic-ischemic events, infections, hemorrhage, congenital malformations, and genetic metabolic disorders.
Rate of neonatal brain injuryFrom inclusion to deliveryBrain injury refers to damage to the central nervous system resulting from various risk factors during pregnancy, childbirth, and the neonatal period. Clinically, it manifests as central motor disorders, cognitive impairments, language disorders, visual and auditory impairments, as well as difficulties in social interaction and psychological and behavioral disorders. It needs pregnant history or birth history, (such as one of twin intrauterine fetal death, Intrauterine distress), manifestation, and ultrasound, CT, MRI, electroencephalogram to make a definite diagnosis.
Rate of early childhood developmental delay of the offspringWithin 1 year after deliveryEarly childhood developmental delay of the offspring refers to a significant lag or delay in achieving age-appropriate developmental milestones across one or more domains, including cognitive, language, motor, social-emotional, and adaptive skills, during the early years of life (typically from birth to 5 years of age) in comparison to established norms or peers. The assessment of early childhood developmental delay is conducted using standardized scales such as Ages Stages Questionnaires (Third Edition), Gesell Developmental Schedules, and Bayley Scales of Infant and Toddler Development. The actual measurement process will be depending on the routine pediatric settings and resources available at each participating institution.

Secondary

MeasureTime frameDescription
Rate of sleep disordersFrom inclusion to deliveryWomen's physiological and psychological changes during pregnancy will affect sleep, and the occurrence of bad sleep during pregnancy is more common. It is generally assessed by a sleep questionnaire.
Rate of mental and phycological disordersFrom inclusion to deliveryMaternal mental health is as important as physical health, and good maternal mental health helps to promote the physical and mental health of the baby, as well as their own physical condition and natural childbirth. The condition of pregnant women is generally assessed by psychiatric departments.
Rate of single intrauterine fetal demiseFrom inclusion to deliveryThe death of one fetus for twin pregnancy,the occurrence in the second and third trimesters of pregnancy has substantial adverse effects on surviving infants.
Rate of gestational hypertensionFrom inclusion to deliveryTake two consecutive measurements on the same arm, the systolic blood pressure more than 140 mmHg and (or) the diastolic blood pressure more than 90 mmHg. High blood pressure may lead to severe complications such as preclampsia and clampsia.
Rate of gestational diabetes mellitusFrom inclusion to deliveryDiagnosed with gestational diabetes through an oral glucose tolerance test (OGTT). The blood glucose threshold of fasting, 1 h and 2 h after taking oral glucose was 5.1, 10.0, 8.5 mmolL, respectively, and the blood glucose level reached or exceeded the above criteria at any time point was diagnosed as GDM. GDM is clearly associated with adverse pregnancy outcomes such as fetal macrosomia, cesarean section delivery, preterm birth, and preeclampsia
Number of maternal deathFrom inclusion to deliveryDeaths during pregnancy or less than 42 days after termination of pregnancy.
Rate of stillbirthFrom inclusion to deliveryAfter 28 gestational weeks, the fetus dies before or during delivery
Birth weightAt deliveryEach newborn is measured twice. If the difference is less than 0.01 kg, the average of the two measurements is taken. If the difference is greater than 0.01 kg, the measurement is repeated.
Birth lengthAt deliveryEach newborn is measured twice. If the difference is less than 0.1 cm, the average of the two measurements is taken. If the difference is greater than 0.1 cm, the measurement is repeated.

Countries

China

Contacts

Primary ContactYuan Wei, PhD, MD
weiyuanbysy@163.com01082267852
Backup ContactTianchen Wu, PhD
wtc17@pku.edu.cn

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026